REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kardu Pharma S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Offices of Real Estate Agents and Brokers
Full name: Kardu Pharma S.A.S Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Kardu Pharma S.A.S is a company in Colombia, with a head office in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 10, 2024. There are currently 14 (2026) people employed by Kardu Pharma S.A.S. In 2025, the company reported a net sales revenue increase of 234.31%. Its’ total assets recorded a growth of 80.93%. The net profit margin of Kardu Pharma S.A.S increased by 1.96% in 2025.

Headquarters
Carrera 13 96 67 Oficina 513
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Kardu Pharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Kardu Pharma S.A.S report to view the information.
Financial Auditors:
Purchase the Kardu Pharma S.A.S report to view the information.
Incorporation Date:
January 10, 2024
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Kardu Pharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
234.31%▲
Total Operating Revenue
234.31%▲
Operating Profit
60.39%▲
Net Profit/Loss for the Period
346.28%▲
Total Assets
80.93%▲
Total Equity
442.3%▲
Operating Profit Margin
-7.56%▼
Net Profit Margin
1.96%▲
Return on Equity (ROE)
-17.71%▼
Quick Ratio
0.08%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo